Temporal changes in salivary glands of non-obese diabetic mice as a model for Sjögren’s syndrome

Effect of Soluble ICAM-1 on a Sjögren's Syndrome-like Phenotype in NOD Mice Is Disease Stage Dependent

(2011) Nienke Roescher et al.   PLoS One

Effectiveness of rituximab treatment in primary Sjögren's syndrome: A randomized, double-blind, placebo-controlled trial

(2010) J. M. Meijer et al.   ARTHRITIS AND RHEUMATISM

Interleukin-12 induces salivary gland dysfunction in transgenic mice, providing a new model of Sjögren's syndrome

(2009) Jelle L. Vosters et al.   ARTHRITIS AND RHEUMATISM

Clinical and histologic evidence of salivary gland restoration supports the efficacy of rituximab treatment in Sjögren's syndrome

(2009) J. Pijpe et al.   ARTHRITIS AND RHEUMATISM

Sjögren syndrome: Advances in the pathogenesis from animal models

(2009) J.A. Chiorini et al.   JOURNAL OF AUTOIMMUNITY

Characteristics of the minor salivary gland infiltrates in Sjögren's syndrome

(2009) Maria I. Christodoulou et al.   JOURNAL OF AUTOIMMUNITY

Cftr and ENaC ion channels mediate NaCl absorption in the mouse submandibular gland

(2009) Marcelo A. Catalán et al.   JOURNAL OF PHYSIOLOGY-LONDON

Cytokines in Sjögren’s syndrome

(2009) N Roescher et al.   ORAL DISEASES

Viruses induce high expression of BAFF by salivary gland epithelial cells through TLR- and type-I IFN-dependent and -independent pathways

(2008) Marc Ittah et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Mucosa-Associated Lymphoid Tissue Lymphoma in Sjögren's Syndrome: Risks, Management, and Prognosis

(2008) Michael Voulgarelis et al.   RHEUMATIC DISEASE CLINICS OF NORTH AMERICA